Market Tracker

07/26 3:55pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

7.53
BATS BZX Real-Time Price
As of 3:55pm ET
 +0.105 / +1.42%
Today’s Change
2.80
Today|||52-Week Range
8.31
+49.01%
Year-to-Date

Today’s Trading

Previous close7.42
Today’s open7.37
Day’s range7.36 - 7.55
Volume63,195
Average volume (3 months)1,563,758
Market cap$785.2M
Dividend yield--
Data as of 3:55pm ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)+3.25%
Earnings growth (this year)+20.43%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+26.37%
P/E ratioNM
Price/Sales38.35
Price/Book8.97

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.33+5.50%
XNCRXencor Inc-0.24-1.30%
AMPHAmphastar Pharmaceut...+0.01+0.06%
EGRXEagle Pharmaceutical...-0.56-1.21%
Data as of 3:55pm ET, 07/26/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$13.7M
Annual profit (last year)-$123.1M
Net profit margin-900.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
Boston, Massachusetts

Forecasts